You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology II1 Apr 2018MP73-05 KARL STORZ® DRILLCUT™ VERSUS LUMENIS® VERSACUT™ PROSTATE TISSUE MORCELLATORS AFTER HOLMIUM LASER ENUCLEATION: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL Ahmed Ibrahim, Mostafa Elhilali, Sero Andonian, and Serge Carrier Ahmed IbrahimAhmed Ibrahim More articles by this author , Mostafa ElhilaliMostafa Elhilali More articles by this author , Sero AndonianSero Andonian More articles by this author , and Serge CarrierSerge Carrier More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2369AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The DrillCutTM morcellator has been recently introduced by Karl Storz® with unique features designed to optimize the critical step of the procedure. To date, the comparative efficacy of the new Karl Storz® DrillCutTM device remains undetermined. Therefore, the objective of the present study was to compare safety, efficacy and cost effectiveness outcomes between the new Karl Storz® DrillCutTM and Lumenis® VersaCutTM prostate tissue morcellators after holmium laser enucleation of the prostate (HoLEP). METHODS After obtaining ethics approval, consecutive patients undergoing HoLEP for symptomatic benign prostatic hyperplasia were randomized to have their enucleated prostates morcellated by either Karl Storz® DrillCutTM or Lumenis® VersaCutTM morcellators. All procedures were performed by two experienced urologists. Patients′ demographics and peri-operative data were recorded. Both morcellators were compared for their safety, efficacy and cost-effectiveness. RESULTS A total of 82 patients were included in the study (41 per each arm). Both groups were comparable in terms of age, pre-operative prostate size (114 vs. 112 mL, p>0.05), enucleation time (95.3 vs. 91.7 min, p> 0.05) and morcellation time (21.6 vs. 18.3 min, p>0.05). However, the DrillCutTM morcellator was associated with significantly lower morcellation efficiency when compared with the VersaCutTM morcellator (3.8% vs. 4.9% g/min, p= 0.03). There was no significant difference between both morcellators in terms of complication rates (7.3 vs. 2.4%, P =0.1). There was one case of small bladder perforation requiring abdominal exploration with the VersaCutTM morcellator. The cost of disposable instruments were higher with the new DrillCutTM morcellator when compared with the VersaCutTM morcellator (247.5 vs. 160.9 CAD $, p<0.01). CONCLUSIONS The new Karl Storz® DrillCutTM morcellator was associated with significantly lower morcellation efficiency and higher cost of disposables when compared with Lumenis® VersaCutTM morcellator. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e992 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Ahmed Ibrahim More articles by this author Mostafa Elhilali More articles by this author Sero Andonian More articles by this author Serge Carrier More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...